• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄甾酮3β-取代衍生物作为3型17β-羟基类固醇脱氢酶的抑制剂

Androsterone 3beta-substituted derivatives as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase.

作者信息

Ngatcha B T, Luu-The V, Poirier D

机构信息

Medicinal Chemistry Division, Oncology and Molecular Endocrinology Research Center, Laval University Medical Center (CHUL) and Laval University, Quebec, Canada.

出版信息

Bioorg Med Chem Lett. 2000 Nov 20;10(22):2533-6. doi: 10.1016/s0960-894x(00)00517-5.

DOI:10.1016/s0960-894x(00)00517-5
PMID:11086723
Abstract

Androsterone derivatives substituted at position 3 were synthesized starting from dihydrotestosterone in a short sequence of reactions. They proved to be potent inhibitors (IC50 = 57-147 nM) of type 3 17beta-hydroxysteroid dehydrogenase, a key enzyme of steroidogenesis, which catalyzes the transformation of androstenedione to steroid active androgen testosterone.

摘要

以双氢睾酮为起始原料,通过短反应序列合成了在3位被取代的雄甾酮衍生物。它们被证明是3型17β-羟基类固醇脱氢酶的有效抑制剂(IC50 = 57 - 147 nM),3型17β-羟基类固醇脱氢酶是类固醇生成的关键酶,催化雄烯二酮转化为具有活性的雄激素睾酮。

相似文献

1
Androsterone 3beta-substituted derivatives as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase.雄甾酮3β-取代衍生物作为3型17β-羟基类固醇脱氢酶的抑制剂
Bioorg Med Chem Lett. 2000 Nov 20;10(22):2533-6. doi: 10.1016/s0960-894x(00)00517-5.
2
Androsterone 3alpha-ether-3beta-substituted and androsterone 3beta-substituted derivatives as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase: chemical synthesis and structure-activity relationship.作为3型17β-羟基类固醇脱氢酶抑制剂的雄甾酮3α-醚-3β-取代物及雄甾酮3β-取代衍生物:化学合成与构效关系
J Med Chem. 2005 Aug 11;48(16):5257-68. doi: 10.1021/jm058179h.
3
3Beta-alkyl-androsterones as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase: inhibitory potency in intact cells, selectivity towards isoforms 1, 2, 5 and 7, binding affinity for steroid receptors, and proliferative/antiproliferative activities on AR+ and ER+ cell lines.3β-烷基雄甾酮作为3型17β-羟基类固醇脱氢酶的抑制剂:在完整细胞中的抑制效力、对同工型1、2、5和7的选择性、对类固醇受体的结合亲和力以及对AR+和ER+细胞系的增殖/抗增殖活性。
Mol Cell Endocrinol. 2006 Mar 27;248(1-2):225-32. doi: 10.1016/j.mce.2005.10.023. Epub 2005 Dec 15.
4
Development of 3-substituted-androsterone derivatives as potent inhibitors of 17β-hydroxysteroid dehydrogenase type 3.3-取代雄甾酮衍生物的开发作为 17β-羟甾脱氢酶 3 型的有效抑制剂。
Bioorg Med Chem. 2011 Aug 1;19(15):4652-68. doi: 10.1016/j.bmc.2011.06.003. Epub 2011 Jun 13.
5
Androsterone derivatives substituted at position 16: chemical synthesis, inhibition of type 3 17beta-hydroxysteroid dehydrogenase, binding affinity for steroid receptors and proliferative/antiproliferative activity on Shionogi (AR+) cells.16位取代的雄甾酮衍生物:化学合成、对3型17β-羟基类固醇脱氢酶的抑制作用、对类固醇受体的结合亲和力以及对Shionogi(AR+)细胞的增殖/抗增殖活性
J Enzyme Inhib Med Chem. 2002 Jun;17(3):155-65. doi: 10.1080/1475636021000002067.
6
In vitro and in vivo evaluation of a 3β-androsterone derivative as inhibitor of 17β-hydroxysteroid dehydrogenase type 3.体外和体内评估 3β-雄甾酮衍生物作为 17β-羟甾脱氢酶类型 3 的抑制剂。
J Steroid Biochem Mol Biol. 2014 May;141:44-51. doi: 10.1016/j.jsbmb.2013.12.019. Epub 2014 Jan 13.
7
Synthesis of 3-spiromorpholinone androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3.合成 3-螺吗啉酮雄甾酮衍生物作为 17β-羟甾脱氢酶 3 型抑制剂。
Bioorg Med Chem Lett. 2013 Dec 1;23(23):6360-2. doi: 10.1016/j.bmcl.2013.09.072. Epub 2013 Oct 7.
8
Design, chemical synthesis and biological evaluation of 3-spiromorpholinone/3-spirocarbamate androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3.3-螺吗啉酮/3-螺氨基甲酸酯雄甾酮衍生物作为3型17β-羟基类固醇脱氢酶抑制剂的设计、化学合成及生物学评价
Bioorg Med Chem. 2015 Sep 1;23(17):5433-51. doi: 10.1016/j.bmc.2015.07.049. Epub 2015 Jul 29.
9
Spironolactone-related inhibitors of type II 17beta-hydroxysteroid dehydrogenase: chemical synthesis, receptor binding affinities, and proliferative/antiproliferative activities.螺内酯相关的II型17β-羟基类固醇脱氢酶抑制剂:化学合成、受体结合亲和力及增殖/抗增殖活性
Bioorg Med Chem. 1999 Jun;7(6):1013-23. doi: 10.1016/s0968-0896(98)00260-0.
10
Inhibitors of type II 17beta-hydroxysteroid dehydrogenase.II型17β-羟基类固醇脱氢酶抑制剂
Mol Cell Endocrinol. 2001 Jan 22;171(1-2):119-28. doi: 10.1016/s0303-7207(00)00427-5.

引用本文的文献

1
A Targeted Bivalent Androgen Receptor Binding Compound for Prostate Cancer Therapy.用于前列腺癌治疗的靶向双价雄激素受体结合化合物。
Horm Cancer. 2019 Feb;10(1):24-35. doi: 10.1007/s12672-018-0353-6. Epub 2018 Dec 18.
2
Solid-phase synthesis of model libraries of 3alpha,17beta-dihydroxy-16alpha-(aminoethyl-N-substituted)-5alpha-androstanes for the development of steroidal therapeutic agents.用于甾体治疗药物研发的3α,17β-二羟基-16α-(氨乙基-N-取代)-5α-雄甾烷模型库的固相合成
Mol Divers. 2005;9(1-3):67-79. doi: 10.1007/s11030-005-1312-z.